GSK1278863A

DRUG4 trials

Sponsors

GlaxoSmithKline

Conditions

AnaemiaKidney Disease

Phase 1

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects

CompletedNCT00750256

GlaxoSmithKlineAnaemia

Start: 2008-07-07End: 2008-12-12Updated: 2017-07-21

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

CompletedNCT00935831

GlaxoSmithKlineKidney Disease

Start: 2009-08-12End: 2010-04-27Updated: 2017-07-27

Relative Bioavailability Study for GSK1278863A

CompletedNCT01319006

GlaxoSmithKlineAnaemia

Start: 2011-02-25End: 2011-04-18Updated: 2017-06-26

Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects

CompletedNCT02348372

GlaxoSmithKlineAnaemia

Start: 2011-03-31End: 2011-06-03Updated: 2017-06-22